Drug treatment of functional dyspepsia: A meta-analysis of randomized controlled clinical trials

Journal of Clinical Gastroenterology

Volumn 11, Issue 2, 1989, Pages 169-177

  Dobrilla, G ^a,b   Comberlato, M ^a,b   Steele, A ^a,b   Vallaperta, P ^a,b  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

Author keywords

Functional dyspepsia; Meta analysis; Ran domized controlled clinical trials

Indexed keywords

CIMETIDINE; CISAPRIDE; DOMPERIDONE; METOCLOPRAMIDE; PIRENZEPINE;

CONTROLLED STUDY; DYSPEPSIA; HUMAN; MAJOR CLINICAL STUDY; META ANALYSIS; PRIORITY JOURNAL; REVIEW;

CLINICAL TRIALS; DYSPEPSIA; GASTROINTESTINAL MOTILITY; HISTAMINE H2 ANTAGONISTS; HUMAN; META-ANALYSIS; PIRENZEPINE; RANDOM ALLOCATION;

EID: 0024520544     PISSN: 01920790     EISSN: 15392031     Source Type: Journal    
DOI: 10.1097/00004836-198904000-00011     Document Type: Article

References (62)

1. Petersen H, Fjosne U, Johannessen T, et al. Clinical significance of upper abdominal symptoms. Scand J Gastroenterol 1985; 20 (suppl 109): 19-22.
2. Thompson WC. Non-ulcer dyspepsia [Editorial]. Can Med Assoc J 1984; 130: 565-9.
3. Dobrilla G. Functional dyspepsia: problems of classification, pathophysiology, diagnosis and therapy. In: Cheli R, Molinari F, eds. Pirenzepine-knowledge and new trends. Verona and New York: Cortina International-Raven Press, 1986: 43-8.
4. Talley NJ, Piper DV. The association between non-ulcer dyspepsia and other gastrointestinal disorders. Scand J Gastroenterol 1985; 20: 896-900.
5. Dobrilla G, Amplatz S. Dietetic approach to patients with functional dyspepsia. In: Barbara L, Bianchi Porro G, Cheli R, Lipkin M, eds. Nutrition in gastrointestinal disease. New York: Raven Press, 1987: 27-39.
6. Talley NJ. Non-ulcer dyspepsia. What measures help? Curr Ther 1986; 27: 81-97.
7. Dobrilla G. Drug treatment of functional dyspepsia: a critical evaluation. GI Report 1987; 2, 6: 1-7.
8. Greenlaw R, Sheahan DG, DeLuca V, Miller D, Myrson D, Myrson P. Gastroduodenitis: a broader concept of gastric ulcer disease. Dig Dis Sci 1980; 25: 660-72.
9. Lagarde SP, Spiro HM. Non-ulcer dyspepsia. Clin Gastroenterol 1984; 13: 437-46.
10. Petersen H. Further investigations and treatment of non-ulcer dyspepsia. Scand J Gastroenterol 1982; 17 (suppl 79): 130-4.
11. Wolff S, Wolff HG. Human gastric function. New York: Oxford University Press, 1943.
12. Johnson AG. Flatulent dyspepsia. Postgrad Med J 1973; 49: 104-6.
13. Capper W, Butler TJ, Kilby JO, Gibson MJ. Gallstones, gastric secretion and flatulent dyspepsia. Lancet 1967; 1: 413-5.
14. Rees WDW, Miller LJ, Malagelada JR. Dyspepsia, antral motor dysfunction and gastric stasis of solids. Gastroenter-ology 1980; 78: 360-5.
15. You Chul H, Chey WY, Lee KY, Menguy L, Bortoff A. Gastric and small intestinal myoelectric dysrhythmia associated with chronic intractable nausea and vomiting. Ann Intern Med 1981; 95: 449-51.
16. Liberati A. Cenni sull’uso della meta-analisi in medicina. Ricerca e Pratica 1986; 11: 143-52.
17. Sacks HS, Berrier J, Reitman D, Ancona-Berk VA, Chalmers TC. Meta-analyses of randomized controlled trials. New Engl J Med 1987; 316: 450-5.
18. Cheli R. Symptoms in chronic non-specific duodenitis. Scand J Gastroenterol 1982; 17 (suppl 79): 84-6.
19. Siurala M, Varis KV. Gastritis. In: Sircus W, Smith AN, eds. Scientific foundations of gastroenterology. London: William Heinemann Medical Books, 1980: 357-69.
20. Talley NJ, McNeil D, Heyden A, Piper DW. Randomized double-blind placebo-controlled cross-over trial of cimetidine and pirenzepine in non-ulcer dyspepsia. Gastroenterology 1986; 91: 149-56.
21. Gasbarrini G, D’Anchino M, Di Tommaso B, et al. Pirenzepine in the treatment of benign gastrointestinal disease. Scand J Gastroenterol 1979; 14 (suppl 57): 25-31.
22. Nyrén O, Adami HO, Bates S, et al. Absence of therapeutic benefit from antacids or cimetidine in non-ulcer dyspepsia. New Engl J Med 1986; 314: 339-43.
23. La Brooy S, Lowel D, Misiezwicz JJ. The treatment of non-ulcer dyspepsia. In: Wasted C, Lance P, eds. Cimetidine. The Westminster Symposium, 6th ed. Edinburgh: Churchill Livingstone, 1978: 131-40.
24. Cleveland PM. The effect of cimetidine in non-ulcer dyspepsia. Experience with a multi-cross-over model. Scand J Gastroenterol 1985; 20: 19-24.
25. Casiraghi A, Ferrara A, Lesinigo E, et al. Cimetidine vs antacids in non-ulcer dyspepsia. Curr Ther Res 1986; 39: 388-97.
26. Panijel M. The treatment of non-ulcer dyspepsia. A comparison of the efficacy and safety of cimetidine and antacid. Z Allgemeinmed 1985; 61: 952-5.
27. Fedeli G, Rapaccini GL, De Vitis J, et al. Pirenzepine vs cimetidine in non-ulcer-associated gastritis and duodenitis. A study of pirenzepine (Gastrozepin) vs cimetidine. Clin Trials J 1983; 20: 104-14.
28. Johnson AG. Controlled trial of metoclopramide in the treatment of flatulent dyspepsia. Br Med J 1971; 2: 25-6.
29. Nagler J, Miskovitz P. Clinical evaluation of domperidone in the treatment of chronic post-prandial idiopathic upper gastrointestinal distress. Am J Gastroenterol 1981; 66: 495-9.
30. Arts E, Anthoni H, de Roy G, D’Hollander J, Ferhaegen H. Domperidone in the treatment of dyspepsia: a double-blind placebo-controlled study. J Int Med Res 1979; 7: 158-61.
31. Sarin SK, Sharma P, Chawia YK, Gopinath P, Nundy S. Clinical trial on the effect of domperidone on non-ulcer dyspepsia. Indian J Med Res 1986; 83: 623-8.
32. Agorastos I, Zissis NP, Caprinis I, Goulis G. Double-blind evaluation of domperidone in acute vomiting and dyspeptic disorders. J Int Med Res 1981; 9: 143-7.
33. Haarmann K, Lebkuchner F, Widmann A, Kief W. A double-blind study of domperidone in the symptomatic treatment of chronic post-prandial upper gastrointestinal distress. Postgrad Med J 1979; 55 (suppl l): 24-7.
34. O’Shea M. A double-blind comparison of domperidone and metoclopramide in the treatment of post-prandial dyspeptic symptoms. Curr Ther Res 1980; 28: 367-70.
35. Moriga M. A multicentre double-blind study of domperidone and metoclopramide in the symptomatic control of dyspepsia. In: Progress with domperidone, a gastrokinetic and antiemetic agent. J R Soc Med 1980; 36: 77-9.
36. Corinaldesi R, Stanghellini V, Roiti C, Rea E, Salgemini R, Barbara L. Effect of chronic administration of cisapride on gastric emptying of a solid meal and on dyspeptic symptoms in patients with idiopathic gastroparesis. Gut 1987; 28: 300-5.
37. Dal Monte PR, D’Imperio N, Accardo P, Giuliani Piccari G, Mazzetti A. Pirenzepine in non-ulcer dyspepsia: a double-blind, placebo-controlled trial. In: Doteval G, ed. Advances in gastroenterology with the selective antimuscrinic compound-pirenzepine. Amsterdam: Excerpta Medica, 1982: 163-9.
38. Dal Monte PR, Giuliani Piccari G, D’Imperio N, et al. Pirenzepine for the treatment of non-ulcer dyspepsia: results of a double-blind multicentre trial. In: Bettarello A, ed. Symposium on pirenzepine: new aspects in research and therapy, Lisbon 1984. Proceedings. Amsterdam: Excerpta Medica, 1985: 93-100.
39. Hradsky M, Wikander M. Effect of pirenzepine in the treatment of non-ulcer dyspepsia: a double-blind study. In: Doteval G, ed. Advances in gastroenterology with the selective antimuscarinic compound-Pirenzepine. Amsterdam: Excerpta Medica, 1982: 170-2.
40. Delattre M, Malesky M, Prinzie A. Symptomatic treatment of non-ulcer dyspepsia with cimetidine. Curr Ther Res 1985; 37: 980-91.
41. Lance P, Filipe MI, Wastell C. Non-ulcer dyspepsia, duodenitis and cimetidine. In: Wastell C, Lance P, eds. Cimetidine. The Westminster Symposium, 6th ed. Edinburgh: Churchill Livingstone, 1978: 126-30.
42. Makinnon M, Willing RL, Whitehead R. Cimetidine in the management of symptomatic patients with duodenitis. A double-blind controlled trial. Dig Dis Sci 1982; 27: 217-9.
43. Nesland AA, Berstad A. Effect of cimetidine in patients with non-ulcer dyspepsia and erosive prepyloric changes. Scand J Gastroenterol 1985; 20: 629-35.
44. Saunders JHB, Oliver RJ, Higson DL. Dyspepsia: incidence of non-ulcer disease in a controlled trial of ranitidine in general practice. Br Med J 1986; 292: 655-68.
45. Kelbaek H, Linde J, Eriksen J, Muntegaard S, Moesgaard F, Bonnevie O. Controlled clinical trial of treatment with cimetidine for non-ulcer dyspepsia. Acta Med Scand 1985; 217: 281-7.
46. De Loose F. Domperidone in chronic dyspepsia: a pilot open study and a multicentre general practice cross-over comparison with metoclopramide and placebo. Pharmatherapeutica 1979; 2: 140-6.
47. Milo R. Use of the peripheral dopamine antagonist, domperidone, in the management of gastrointestinal symptoms in patients with irritable bowel syndrome. Curr Med Res Opin 1980; 6: 577-84.
48. Bekhti A, Rutgeerts L. Domperidone in the treatment of functional dyspepsia in patients with delayed gastric emptying. Postgrad Med J 1979; 55 (suppl l): 30-2.
49. Van de Mierop L, Rutgeerts L, Van den Langenbergh B, Staessen A. Oral domperidone in chronic post-prandial dyspepsia. A double-blind placebo-controlled evaluation. Digestion 1979; 19: 244-50.
50. Van Ganse W, Van Damme L, Van de Mierop L, Deruyttere M, Lauwers W, Coenegrachts J. Chronic dyspepsia: doubleblind treatment with domperidone (R33812) or a placebo. A multicentre therapeutic evaluation. Curr Ther Res 1978; 23: 695-701.
51. Creytens G. Effect of the non-antidopaminergic drug cisa-pride on post-prandial nausea. Curr Ther Res 1984; 36: 1063-9.
52. Milo R. Non-cholinergic, non-antidopaminergic treatment of chronic digestive symptoms suggestive of a motility disorder: a two-step pilot evaluation of cisapride. Curr Ther Res 1984; 36: 1053-61.
53. François I, De Nutte N. Cisapride in the treatment of functional non-ulcer dyspepsia. Digestion 1986; 34: 151.
54. Rösch W. Cisapride in non-ulcer dyspepsia. Scand J Gastroenterol 1987; 22: 161-4.
55. Fleiss JL. Statistical methods for rates and proportions. New York: John Wiley, 1981.
56. Snedecor CW, Cochran WG. Statistical methods, 6th ed. Ames, Iowa: Iowa State University Press, 1967: 593.
57. Jaup BH. The mode of action of pirenzepine in man with special reference to its anticholinergic muscarinic properties. Scand J Gastroenterol 1981; S68: 1-26.
58. 2-receptor antagonists on gastrointestinal motility. Agents Actions 1983; 13: 157-62.
59. 2-antagonisti e motilità gastrointestinale. In: Dobrilla G, Chilovi F, Felder M, eds. Ulcera peptica, recidiva ulcerosa, emorragie digestive: recenti acquisizioni. Verona: Cortina International, 1987: 17-21.
60. Elashoff JD. Combining results of clinical trials. Gastroen-terology 1978; 75: 1170-2.
61. Goldman L, Feinstein AR. Anticoagulants and myocardial infarction: the problems of pooling, drowning and floating. Ann Intern Med 1979; 90: 92-4.
62. Chan SS, Sacks HS, Chalmers TC. The epidemiology of unpublished randomized controlled trials. Clin Res 1982; 30: 234A.